Development of Selective M5 Muscarinic Acetylcholine Receptor Negative Allosteric Modulators for the Prevention of Opioid Misuse and Relapse

被引:0
|
作者
Jones, Carrie [1 ]
Gould, Robert [1 ]
Gunter, Barak [1 ]
Bubser, Michael [1 ]
Matthews, Robert [1 ]
Teal, Laura [1 ]
Robb, Hudson [1 ]
Ragland, Madeline [1 ]
Bridges, Tom [1 ]
Garrison, Aaron [1 ]
Winder, Danny [1 ]
Lindsley, Craig [1 ]
机构
[1] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
关键词
M5 Muscarinic Receptor; Negative Allosteric Modulator; Opioid Use Disorder; Oxycodone;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
W159
引用
下载
收藏
页码:470 / 471
页数:2
相关论文
共 50 条
  • [21] Development of a Photoactivatable Allosteric Ligand for the M1 Muscarinic Acetylcholine Receptor
    Davie, Briana J.
    Sexton, Patrick M.
    Capuano, Ben
    Christopoulos, Arthur
    Scammells, Peter J.
    ACS CHEMICAL NEUROSCIENCE, 2014, 5 (10): : 902 - 907
  • [22] The M5 muscarinic acetylcholine receptor third intracellular loop regulates receptor function and oligomerization
    Borroto-Escuela, Dasiel O.
    Garcia-Negredo, Gloria
    Garriga, Pere
    Fuxe, Kjell
    Ciruela, Francisco
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (07): : 813 - 825
  • [23] Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
    Ma, Lei
    Seager, Matthew
    Wittmann, Marion
    Jacobson, Marlene
    Bickel, Denise
    Burno, Maryann
    Jones, Keith
    Graufelds, Valerie Kuzmick
    Xu, Guangping
    Pearson, Michelle
    McCampbell, Alexander
    Gaspar, Renee
    Shughrue, Paul
    Danziger, Andrew
    Regan, Christopher
    Flick, Rose
    Pascarella, Danette
    Garson, Susan
    Doran, Scott
    Kreatsoulas, Constantine
    Veng, Lone
    Lindsley, Craig W.
    Shipe, William
    Kuduk, Scott
    Sur, Cyrille
    Kinney, Gene
    Seabrook, Guy R.
    Ray, William J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (37) : 15950 - 15955
  • [24] M1 and M5 muscarinic acetylcholine receptor-mediated leukocyte migration
    Harada, Kosuke
    Matsumoto, Yuji
    Umemura, Kazuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 173P - 173P
  • [25] Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators
    May, LT
    Lin, Y
    Sexton, PM
    Christopoulos, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (01): : 382 - 390
  • [26] Discovery and structure -activity relationships study of positive allosteric modulators of the M 3 muscarinic acetylcholine receptor
    Tanaka, Hiroaki
    Negoro, Kenji
    Koike, Takanori
    Tsukamoto, Issei
    Yokoyama, Kazuhiro
    Maeda, Jun
    Inagaki, Yusuke
    Shimoshige, Yukinori
    Ino, Katsutoshi
    Ishizu, Kenichiro
    Takahashi, Taisuke
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (13)
  • [27] CLONING AND EXPRESSION OF THE HUMAN AND RAT M5 MUSCARINIC ACETYLCHOLINE-RECEPTOR GENES
    BONNER, TI
    YOUNG, AC
    BRANN, MR
    BUCKLEY, NJ
    NEURON, 1988, 1 (05) : 403 - 410
  • [28] Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology
    Yamada, M
    Basile, AS
    Fedorova, I
    Zhang, WL
    Duttaroy, A
    Cui, YH
    Lamping, KG
    Faraci, FM
    Deng, CX
    Wess, J
    LIFE SCIENCES, 2003, 74 (2-3) : 345 - 353
  • [29] Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia
    Basile, AS
    Fedorova, I
    Zapata, A
    Liu, XG
    Shippenberg, T
    Duttaroy, A
    Yamada, M
    Wess, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) : 11452 - 11457
  • [30] Atypical muscarinic allosteric modulation:: Cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors
    Tränkle, C
    Dittmann, A
    Schulz, U
    Weyand, O
    Buller, S
    Jöhren, K
    Heller, E
    Birdsall, NJM
    Holzgrabe, U
    Ellis, J
    Höltje, HD
    Mohr, K
    MOLECULAR PHARMACOLOGY, 2005, 68 (06) : 1597 - 1610